Drug:
Reaction: MYELOSUPPRESSION
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25037347 |
DE |
59 | 2 |
Myelosuppression, Neutropenia, Alanine aminotransferase decreased, Pyrexia, Anaemia, |
||||
ABEMACICLIB, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 602 | 25037532 |
CN |
69 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, ETOPOSIDE, |
||||
| 603 | 25037541 |
CN |
40 | |
Myelosuppression, |
||||
CAPECITABINE, CAPECITABINE, CAPECITABINE, DENOSUMAB, DENOSUMAB, DENOSUMAB, |
||||
| 604 | 25037575 |
CN |
46 | |
Myelosuppression, |
||||
| 605 | 25037590 |
CN |
70 | 2 |
Myelosuppression, Product use issue, |
||||
IRINOTECAN HYDROCHLORIDE, BEVACIZUMAB, |
||||
| 606 | 25037617 |
CN |
2 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 607 | 25037620 |
CN |
11 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 608 | 25038062 |
VN |
10 | 2 |
Myelosuppression, Transplant rejection, Platelet count, Granulocyte count decreased, Megakaryocytes decreased, Hepatic enzyme increased, Off label use, |
||||
CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MELPHALAN, |
||||
| 609 | 25038104 |
US |
63 | 1 |
Plasmacytoma, Plasma cell myeloma, Myelosuppression, Myelocyte count decreased, Plasma cells increased, Myelocyte percentage decreased, Lymphocyte percentage decreased, |
||||
| 610 | 25038107 |
CN |
48 | 2 |
Myelosuppression, |
||||
| 611 | 25038114 |
CN |
53 | |
Myelosuppression, |
||||
| 612 | 25038135 |
CN |
40 | 2 |
Myelosuppression, White blood cell count decreased, Asthenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 613 | 25038156 |
CN |
49 | |
Myelosuppression, |
||||
| 614 | 25038315 |
CN |
69 | 2 |
Myelosuppression, |
||||
| 615 | 25038351 |
CN |
52 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 616 | 25038753 |
JP |
75 | 2 |
Myelosuppression, Myelosuppression, Febrile neutropenia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, APIXABAN, MAGNESIUM OXIDE, DEFERASIROX, DEFERASIROX, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, SPIRONOLACTONE, LANSOPRAZOLE, TRANEXAMIC ACID, FLUCONAZOLE, OLMESARTAN MEDOXOMIL, |
||||
| 617 | 25038778 |
CN |
70 | 2 |
Myelosuppression, |
||||
BRENTUXIMAB VEDOTIN, EPIRUBICIN HYDROCHLORIDE, DACARBAZINE, |
||||
| 618 | 25029459 |
CN |
35 | 2 |
Myelosuppression, |
||||
DENOSUMAB, DENOSUMAB, DENOSUMAB, DENOSUMAB, DENOSUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 619 | 25029566 |
CN |
54 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, |
||||
| 620 | 25029623 |
CN |
82 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, |
||||
| 621 | 25029776 |
CN |
55 | 1 |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 622 | 25029890 |
CN |
39 | |
Myelosuppression, |
||||
FULVESTRANT, FULVESTRANT, DENOSUMAB, GOSERELIN, |
||||
| 623 | 25030293 |
CN |
60 | |
Myelosuppression, Platelet count decreased, Epistaxis, |
||||
OSIMERTINIB, BEVACIZUMAB, |
||||
| 624 | 25030353 |
CN |
65 | 2 |
White blood cell count decreased, Platelet count decreased, Myelosuppression, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EPIRUBICIN HYDROCHLORIDE, VINCRISTINE SULFATE, |
||||
| 625 | 25030438 |
NL |
1 | |
Septic shock, Encapsulating peritoneal sclerosis, Abdominal sepsis, Intestinal perforation, Myelosuppression, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 626 | 25030448 |
JP |
||
Myelosuppression, |
||||
ATEZOLIZUMAB, PACLITAXEL, CARBOPLATIN, |
||||
| 627 | 25030451 |
CN |
61 | 2 |
Myelosuppression, |
||||
CARFILZOMIB, DARATUMUMAB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 628 | 25030502 |
CN |
78 | 2 |
Myelosuppression, Pyrexia, White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Haemoglobin decreased, Palpitations, Dyspnoea, Cough, |
||||
RITUXIMAB, RITUXIMAB, BENDAMUSTINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MEROPENEM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 629 | 25030511 |
CN |
78 | 1 |
Myelosuppression, Platelet count decreased, Haemoglobin decreased, White blood cell count decreased, Anaemia, |
||||
RITUXIMAB, RITUXIMAB, CISPLATIN, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 630 | 25030575 |
CN |
51 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Off label use, |
||||
NIVOLUMAB, CAPECITABINE, DOCETAXEL, DOCETAXEL ANHYDROUS, CISPLATIN, PACLITAXEL, RAMUCIRUMAB, |
||||
| 631 | 25030640 |
CN |
1 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 632 | 25031083 |
CN |
43 | 2 |
Myelosuppression, Asthenia, Fatigue, |
||||
PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 633 | 25031526 |
NL |
1 | |
Drug ineffective, Myelosuppression, Osteonecrosis, Drug specific antibody present, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 634 | 25031546 |
CN |
49 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 635 | 25032307 |
CN |
2 | 1 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, IRINOTECAN HYDROCHLORIDE, |
||||
| 636 | 25032363 |
CN |
58 | 1 |
Myelosuppression, |
||||
CARFILZOMIB, LENALIDOMIDE, DARATUMUMAB, DARATUMUMAB, |
||||
| 637 | 25032556 |
JP |
3 | 2 |
Acute myeloid leukaemia recurrent, Myelosuppression, Cytarabine syndrome, |
||||
(DAUNORUBICIN AND CYTARABINE) LIPOSOME, |
||||
| 638 | 25032766 |
CN |
68 | 2 |
Myelosuppression, |
||||
DENOSUMAB, |
||||
| 639 | 25032953 |
FR |
52 | |
Death, Left ventricular dysfunction, Myelosuppression, Acquired gene mutation, Dilated cardiomyopathy, |
||||
METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, PONATINIB HYDROCHLORIDE, PONATINIB HYDROCHLORIDE, BLINATUMOMAB, BLINATUMOMAB, BLINATUMOMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 640 | 25033133 |
CN |
72 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, |
||||
| 641 | 25033178 |
CN |
75 | 1 |
Myelosuppression, Hepatic function abnormal, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, |
||||
| 642 | 25033287 |
CZ |
66 | 1 |
Drug ineffective, Neurotoxicity, Myelosuppression, |
||||
ETOPOSIDE, DOXORUBICIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, OXALIPLATIN, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, CYTARABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 643 | 25033340 |
CN |
55 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 644 | 25033368 |
CN |
51 | 2 |
Myelosuppression, Pyrexia, |
||||
RAMUCIRUMAB, CAPECITABINE, DOCETAXEL, DOCETAXEL ANHYDROUS, CISPLATIN, PACLITAXEL, NIVOLUMAB, |
||||
| 645 | 25033369 |
CN |
45 | |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
| 646 | 25033376 |
CN |
65 | |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
| 647 | 25028682 |
CN |
71 | 2 |
Myelosuppression, Epistaxis, |
||||
PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, |
||||
| 648 | 25028838 |
JP |
2 | |
Sepsis, Abdominal adhesions, Ovarian adhesion, Myelosuppression, |
||||
PEMBROLIZUMAB, |
||||
| 649 | 25026316 |
CN |
50 | 1 |
Myelosuppression, |
||||
PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, |
||||
| 650 | 25026321 |
CN |
68 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, |
||||
| 651 | 25026355 |
CN |
56 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, |
||||
| 652 | 25021122 |
CN |
71 | 1 |
Myelosuppression, Asthenia, |
||||
LEUPROLIDE ACETATE, BICALUTAMIDE, |
||||
| 653 | 25021137 |
CN |
53 | |
Agranulocytosis, Myelosuppression, Diarrhoea, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, CARBOPLATIN, |
||||
| 654 | 25021165 |
CN |
60 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, |
||||
| 655 | 25021193 |
CN |
41 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 656 | 25021339 |
CN |
60 | 2 |
Hypothyroidism, Myelosuppression, Hyponatraemia, |
||||
PACLITAXEL, |
||||
| 657 | 25021400 |
CN |
69 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 658 | 25021408 |
CN |
55 | |
Myelosuppression, Hepatic function abnormal, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 659 | 25021616 |
DE |
56 | 1 |
Myelosuppression, Gastrointestinal toxicity, Neutropenia, Thrombocytopenia, |
||||
CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DURVALUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 660 | 25021641 |
CN |
76 | |
Myelosuppression, |
||||
PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 661 | 25021648 |
CN |
53 | 2 |
Myelosuppression, Gastrointestinal disorder, Pyrexia, Abdominal pain, Decreased appetite, |
||||
OXALIPLATIN, OXALIPLATIN, FLUOROURACIL, FLUOROURACIL, |
||||
| 662 | 25021924 |
CN |
62 | |
Myelosuppression, |
||||
FULVESTRANT, FULVESTRANT, PALBOCICLIB, |
||||
| 663 | 25021994 |
CN |
57 | 1 |
Myelosuppression, Anal infection, Secretion discharge, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 664 | 25022049 |
CN |
36 | |
Myelosuppression, Hepatic function abnormal, |
||||
OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, |
||||
| 665 | 25022821 |
IT |
53 | 2 |
Drug ineffective, Neutropenia, Myelosuppression, Hepatotoxicity, Thrombocytopenia, Disease progression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PACLITAXEL, CAPECITABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CARBOPLATIN, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, BLEOMYCIN, BLEOMYCIN SULFATE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, |
||||
| 666 | 25022831 |
CN |
51 | 2 |
Myelosuppression, Diarrhoea, |
||||
TRASTUZUMAB, GEMCITABINE HYDROCHLORIDE, |
||||
| 667 | 25023090 |
US |
2 | |
Myelosuppression, Pancytopenia, Septic shock, Pneumonia, |
||||
METHIMAZOLE, |
||||
| 668 | 25023103 |
CN |
55 | 2 |
Leukopenia, Neutropenia, Myelosuppression, Anaemia, Thrombocytopenia, Hyperphosphataemia, Infection, |
||||
CARBOPLATIN, |
||||
| 669 | 25023814 |
IN |
50 | 2 |
Myelosuppression, Hypomagnesaemia, Dehydration, Diarrhoea, Sinus tachycardia, Metabolic alkalosis, Hypocalcaemia, Hypokalaemia, Dysphagia, Cough, Chest discomfort, Asthenia, Metabolic acidosis, Pancytopenia, Leukopenia, Thrombocytopenia, |
||||
OXALIPLATIN, FLUOROURACIL, |
||||
| 670 | 25023832 |
IT |
78 | |
Myelosuppression, Paraesthesia, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PACLITAXEL, RAMIPRIL, BISOPROLOL FUMARATE, CARBOPLATIN, ACARBOSE, FUROSEMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 671 | 25023853 |
IT |
61 | 2 |
Myelosuppression, Hepatotoxicity, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 672 | 25023923 |
JP |
7 | |
Metastases to liver, Myelosuppression, Rash maculo-papular, Nausea, Diarrhoea, |
||||
FULVESTRANT, FULVESTRANT, FULVESTRANT, CAPIVASERTIB, CAPIVASERTIB, CAPIVASERTIB, CAPIVASERTIB, PALBOCICLIB, PALBOCICLIB, ABEMACICLIB, ABEMACICLIB, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, PACLITAXEL, PACLITAXEL, BEVACIZUMAB, |
||||
| 673 | 25024081 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 674 | 25024096 |
CN |
63 | 2 |
Pneumonia, Myelosuppression, Hypokalaemia, Aspartate aminotransferase increased, Anaemia, |
||||
BRENTUXIMAB VEDOTIN, IFOSFAMIDE, IFOSFAMIDE, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, VALSARTAN, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, |
||||
| 675 | 25024149 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 676 | 25024263 |
CN |
42 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 677 | 25024308 |
IN |
6 | 2 |
Hypokalaemia, Myelosuppression, Hypomagnesaemia, Hypocalcaemia, Diarrhoea, Metabolic acidosis, Metabolic alkalosis, |
||||
OXALIPLATIN, FLUOROURACIL, |
||||
| 678 | 25024391 |
CN |
62 | 2 |
Syncope, Dizziness, Asthenia, Abdominal distension, Seizure, Loss of consciousness, Gaze palsy, Staring, Foaming at mouth, Cyanosis, Nausea, Myelosuppression, Pyrexia, Granulocytopenia, Abdominal pain, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, FILGRASTIM, |
||||
| 679 | 25024488 |
CN |
60 | 1 |
Myelosuppression, Hepatic function abnormal, Pyrexia, |
||||
METHOTREXATE SODIUM, CYTARABINE, |
||||
| 680 | 25024660 |
CN |
||
Myelosuppression, |
||||
IFOSFAMIDE, EPIRUBICIN HYDROCHLORIDE, |
||||
| 681 | 25024702 |
CN |
51 | 2 |
Myelosuppression, Mouth haemorrhage, Pancytopenia, Haemorrhage subcutaneous, Hepatic function abnormal, Blood bilirubin increased, Transaminases increased, |
||||
DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, |
||||
| 682 | 25025481 |
CN |
47 | |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 683 | 25025493 |
CN |
36 | |
Myelosuppression, |
||||
CISPLATIN, ETOPOSIDE, |
||||
| 684 | 25025506 |
CN |
55 | |
Myelosuppression, Rash erythematous, |
||||
GEMCITABINE HYDROCHLORIDE, ERLOTINIB HYDROCHLORIDE, |
||||
| 685 | 25025556 |
JP |
64 | 1 |
Myelosuppression, Febrile neutropenia, Septic shock, |
||||
(DAUNORUBICIN AND CYTARABINE) LIPOSOME, ITRACONAZOLE, AMLODIPINE BESYLATE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, |
||||
| 686 | 25025579 |
CN |
57 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, CARBOPLATIN, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 687 | 25015729 |
CN |
42 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, ERIBULIN MESYLATE, ERIBULIN MESYLATE, ERIBULIN MESYLATE, |
||||
| 688 | 25015797 |
CN |
57 | 1 |
Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 689 | 25016291 |
CN |
76 | 1 |
Myelosuppression, |
||||
BEVACIZUMAB, CAPECITABINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 690 | 25016359 |
CN |
59 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 691 | 25016601 |
CN |
42 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, PERTUZUMAB, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, |
||||
| 692 | 25016661 |
CN |
63 | 2 |
Myelosuppression, |
||||
VENETOCLAX, DECITABINE, |
||||
| 693 | 25016924 |
CN |
58 | 2 |
Myelosuppression, Decreased appetite, Nausea, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, OLANZAPINE, |
||||
| 694 | 25017010 |
CN |
66 | 1 |
Myelosuppression, Pyrexia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, OLANZAPINE, |
||||
| 695 | 25017072 |
CN |
55 | 2 |
Myelosuppression, Fatigue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, OLANZAPINE, |
||||
| 696 | 25017153 |
JO |
54 | 2 |
Drug interaction, Myelosuppression, Diarrhoea, |
||||
ALLOPURINOL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, |
||||
| 697 | 25017288 |
IN |
6 | 2 |
Hypokalaemia, Hypomagnesaemia, Hypocalcaemia, Myelosuppression, Diarrhoea, Metabolic acidosis, |
||||
FLUOROURACIL, OXALIPLATIN, FLUOROURACIL, OXALIPLATIN, |
||||
| 698 | 25017926 |
CN |
68 | 2 |
Myelosuppression, Abdominal pain, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, SELINEXOR, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, LENALIDOMIDE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, OLANZAPINE, |
||||
| 699 | 25018005 |
DE |
52 | 1 |
Pneumonia, Leukopenia, Dyspnoea, Pyrexia, Myelosuppression, Nausea, Cholestasis, Disorientation, Respiratory disorder, Thrombocytopenia, Renal failure, |
||||
DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 700 | 25018109 |
CN |
50 | 2 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28